Fundraising Fox

Biotech Investors & VC Firms in China

200 firms in this list, with a median first check of $1.1M. 27 of them lead rounds. Generated from verified public data and updated continuously.

Y Combinator
San FranciscoPre-Seed–Series A$500K
22 people
Qiming Venture Partners
ShanghaiSeed–Growth$5M – $134M
11 people
New Enterprise Associates (NEA)
Menlo ParkSeed–Late Stage$200K – $40M
65 people
Gobi Partners
Hong KongPre-Seed–Late Stage$709K – $37M
74 people
VU Venture Partners
San FranciscoSeed–Series B$200K – $1M
53 people
Source Code Capital
BeijingSeed–Growth$2M – $200M
1 person
Celesta Capital
Menlo ParkSeed–Late Stage$5M – $20M
24 people
Prosperity7 Ventures
DhahranSeries A–Growth
43 people
Vivo Capital
Palo AltoSeed–Late Stage$10M – $50M
25 people
Advent International
BostonSeries A–Late Stage$1.1B
46 people
Novo Holdings
CopenhagenPre-Seed–Late Stage$1.1M – $54M
41 people
Shunwei Capital
Grand CaymanSeed–Growth$1.4M – $100M
27 people
Legend Capital
BeijingPre-Seed–Growth$2.9M – $156M
25 people
VantagePoint Capital Partners
Silicon ValleySeed–Late Stage$2M – $100M
21 people
Artesian
AustraliaPre-Seed–Late Stage
42 people
Decheng Capital
Menlo ParkSeed–Growth
16 people
SOSV
New YorkPre-Seed–Series B$30K – $550K
28 people
Fortune Venture Capital
ShenzhenSeed–Late Stage$425K – $73M
11 people
Linear Capital
ShanghaiPre-Seed–Series A$1M – $10M
18 people
ZhenFund
BeijingPre-Seed–Series B$425K – $28M
27 people
Impact Fund Denmark
CopenhagenSeed–Late Stage$2.2M – $70.2M
36 people
WI Harper Group
San FranciscoSeed–Series C$5M – $15M
25 people
Pan-Lin Capital
ShanghaiPre-Seed–Growth
5 people
K3 Ventures
SingaporeSeed–Growth$1.2M – $42M
23 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.